The Human Genome Organization has re-elected its president Edison Liu. Liu is executive director of the Genome Institute of Singapore and he has been HUGO's president since 2007.
Martin Schneider is now chair of the advisory board of imaGenes, the Berlin-based genomics services company said last week. Schneider replaces Klaus Schmidt-Menschner, who left to pursue other interests. Schneider is head of global therapeutic research at Bayer Schering Pharma. He was previously head of global target discovery and biomarkers at Bayer. Before that, he was head of enabling technologies at Schering.